The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than ...
We decided to exit the Oracle position and book a short-term tax loss, spreading the capital across several of the ...
Feb 11 (Reuters) - Novo Nordisk said on Wednesday it plans to launch its weight-loss pill Wegovy in vials. "We are exploring ...
Eli Lilly is priced for perfection thanks to its GLP-1 drugs, while Wall Street seems to have forgotten about these two ...
The Danish drugmaker kicked off 2026 with its explosive obesity pill launch, but recent challenges have centered around protecting its market share.
Joe Budden discusses using Zepbound, fitness changes, and health awareness during an appearance on 'Club Shay Shay.' ...
Compare Zepbound and Wegovy to understand how one hormone vs two impacts weight loss, appetite control, side effects, and ...
New data shows Wegovy pill uptake: 36% are new to GLP-1s, with many switching from injectable versions. Read more here.
Mounjaro and Zepbound generated a combined $11.7 billion in sales for the company in its most recent quarter.
Despite their huge popularity, GLP-1 injury lawsuits citing the drugs as a cause for a host of severe GI issues and even ...
The government website is meant to connect Americans with drug companies to buy prescriptions directly with their own money.
Stocktwits on MSN
Novo Nordisk reportedly eyes launching Wegovy in vials to compete with rival Eli Lilly
It is unclear what the company intends to charge for the vials, the report said. ・Unlike Novo, Eli Lilly and Company already ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results